SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,586,199 | -11.9% | 19,540,000 | -13.2% | 0.22% | -7.3% |
| Q4 2022 | $22,231,588 | -9.3% | 22,513,000 | -10.5% | 0.23% | -13.0% |
| Q3 2022 | $24,514,000 | +2.8% | 25,143,000 | +2.8% | 0.27% | -2.9% |
| Q2 2022 | $23,851,000 | +21.6% | 24,447,000 | +22.8% | 0.28% | +35.1% |
| Q1 2022 | $19,614,000 | -0.5% | 19,901,000 | 0.0% | 0.20% | -5.1% |
| Q4 2021 | $19,714,000 | -10.7% | 19,901,000 | -10.9% | 0.22% | -29.9% |
| Q3 2021 | $22,068,000 | -0.7% | 22,348,000 | -0.6% | 0.31% | +3.4% |
| Q2 2021 | $22,220,000 | +0.6% | 22,488,000 | -1.4% | 0.30% | -3.2% |
| Q1 2021 | $22,095,000 | +38.5% | 22,802,000 | +36.2% | 0.31% | +12.0% |
| Q4 2020 | $15,957,000 | +107.0% | 16,738,000 | +101.1% | 0.28% | +63.7% |
| Q3 2020 | $7,708,000 | -47.3% | 8,324,000 | -49.6% | 0.17% | -48.1% |
| Q2 2020 | $14,613,000 | – | 16,511,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|